MedPath

Effect of combined supplementation Coenzyme Q10 with L-carnitine on migraine

Early Phase 1
Conditions
migraine.
Migraine, unspecified
Registration Number
IRCT20121216011763N21
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
56
Inclusion Criteria

patients with migraine (with or without aura)
both sex
nonpregnant
nonlactative
nonsmokers
non-alcoholic
willing to participate in the study

Exclusion Criteria

contain history of chronic diseases
chronic tension-type headache or secondary headaches
medication or supplements use
following a diet program during the past 6 month
following exercise program during the past 6 month

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Migraine symptoms ( severity , frequency and average duration of migraine attacks). Timepoint: week 0 and week 8. Method of measurement: Questionaire.;Serum Lactate. Timepoint: week 0 and week 8. Method of measurement: Laboratory analysis (blood test).
Secondary Outcome Measures
NameTimeMethod
Migraine Disability Assessment. Timepoint: week 0 and week 8. Method of measurement: Questinaire.;Depression. Timepoint: week 0 and week 8. Method of measurement: Questinaire.
© Copyright 2025. All Rights Reserved by MedPath